Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predictors of Post-alteplase Hemorrhagic Transformation in Stroke
NCT06337175Phase 4Completed
- Sponsor
- Kafrelsheikh University
- Start
- Jun 2021
- Primary completion
- Oct 2023
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 4, open-label trial of tissue-plasminogen activator in ischemic stroke (2 arms), sponsored by Kafrelsheikh University. Primary endpoint: Predictors of the hemorrhagic infarction type 1 at 48 hours. Started Jun 2021; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06337175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06337175.